Assyro AI

FDA Orange Book · active-ingredient family

Floxuridine

Floxuridine is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:FUDR · NDA 016929

1

Brand (NDA)

3

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
FUDRRLDHOSPIRANDA 016929Approved Prior to Jan 1, 1982

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
FLOXURIDINEAM REGENTANDA 203008Nov 22, 2017
FLOXURIDINEFRESENIUS KABI USAANDA 075837APFeb 22, 2001
FLOXURIDINEHIKMAANDA 075387APApr 16, 2000

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Floxuridine — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.